pBMN(CMV-copGFP-Luc2-Puro) Citations (7)
Originally described in: Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer.Jin C, Fotaki G, Ramachandran M, Nilsson B, Essand M, Yu D EMBO Mol Med. 2016 May 6. pii: e201505869. doi: 10.15252/emmm.201505869. PubMed Journal
Articles Citing pBMN(CMV-copGFP-Luc2-Puro)
Articles |
---|
A Feedforward Mechanism Mediated by Mechanosensitive Ion Channel PIEZO1 and Tissue Mechanics Promotes Glioma Aggression. Chen X, Wanggou S, Bodalia A, Zhu M, Dong W, Fan JJ, Yin WC, Min HK, Hu M, Draghici D, Dou W, Li F, Coutinho FJ, Whetstone H, Kushida MM, Dirks PB, Song Y, Hui CC, Sun Y, Wang LY, Li X, Huang X. Neuron. 2018 Nov 21;100(4):799-815.e7. doi: 10.1016/j.neuron.2018.09.046. Epub 2018 Oct 18. PubMed |
Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo. Brossa A, Fonsato V, Grange C, Tritta S, Tapparo M, Calvetti R, Cedrino M, Fallo S, Gontero P, Camussi G, Bussolati B. Int J Cancer. 2020 Sep 15;147(6):1694-1706. doi: 10.1002/ijc.32925. Epub 2020 Feb 25. PubMed |
Combined Inhibition of Galphaq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma. Hitchman TD, Bayshtok G, Ceraudo E, Moore AR, Lee C, Jia R, Wang N, Pachai MR, Shoushtari AN, Francis JH, Guan Y, Chen J, Chang MT, Taylor BS, Sakmar TP, Huber T, Chi P, Chen Y. Clin Cancer Res. 2021 Mar 1;27(5):1476-1490. doi: 10.1158/1078-0432.CCR-20-2860. Epub 2020 Nov 23. PubMed |
Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts. Almstedt E, Rosen E, Gloger M, Stockgard R, Hekmati N, Koltowska K, Krona C, Nelander S. Neuro Oncol. 2021 Nov 19. pii: 6432157. doi: 10.1093/neuonc/noab264. PubMed |
Pan-cancer ion transport signature reveals functional regulators of glioblastoma aggression. Bahcheli AT, Min HK, Bayati M, Zhao H, Fortuna A, Dong W, Dzneladze I, Chan J, Chen X, Guevara-Hoyer K, Dirks PB, Huang X, Reimand J. EMBO J. 2024 Jan;43(2):196-224. doi: 10.1038/s44318-023-00016-x. Epub 2024 Jan 2. PubMed |
Early rhombic lip Protogenin(+ve) stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma. Visvanathan A, Saulnier O, Chen C, Haldipur P, Orisme W, Delaidelli A, Shin S, Millman J, Bryant A, Abeysundara N, Wu X, Hendrikse LD, Patil V, Bashardanesh Z, Golser J, Livingston BG, Nakashima T, Funakoshi Y, Ong W, Rasnitsyn A, Aldinger KA, Richman CM, Van Ommeren R, Lee JJY, Ly M, Vladoiu MC, Kharas K, Balin P, Erickson AW, Fong V, Zhang J, Suarez RA, Wang H, Huang N, Pallota JG, Douglas T, Haapasalo J, Razavi F, Silvestri E, Sirbu O, Worme S, Kameda-Smith MM, Wu X, Daniels C, MichaelRaj AK, Bhaduri A, Schramek D, Suzuki H, Garzia L, Ahmed N, Kleinman CL, Stein LD, Dirks P, Dunham C, Jabado N, Rich JN, Li W, Sorensen PH, Wechsler-Reya RJ, Weiss WA, Millen KJ, Ellison DW, Dimitrov DS, Taylor MD. Cell. 2024 Aug 22;187(17):4733-4750.e26. doi: 10.1016/j.cell.2024.06.011. Epub 2024 Jul 5. PubMed |
Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer. Devi GR, Pai P, Lee S, Foster MW, Sannareddy DS, Bertucci F, Ueno N, Van Laere S. NPJ Breast Cancer. 2024 Jul 29;10(1):65. doi: 10.1038/s41523-024-00664-0. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.